Emory allegedly billed Medicare and Medicaid for medical care and other clinical trial services paid for by the trial’s sponsors, and was paid twice for some services.
“Our investigation of Emory University revealed the institution’s clinical trial false billing and led to today’s settlement,” said Derrick L. Jackson, special agent in charge of HHS’ Office of Inspector General for the Atlanta region, in a news release. “Protecting Medicare — and taxpayer dollars — remains a top priority.”
The whistle-blower suit was brought forth by a former Emory employee, who will receive a portion of the settlement.
More Articles on False Claims Act Settlements:
Court Ruling Continues Trend of Limiting Use of False Claims Act in Non-Fraud Cases
Medicare Whistle-Blower Earns $2.1M in Settlement
New York Orthopedic Surgeon to Settle False Claims Allegations for $388k
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
